CHARLOTTETOWN, PE & SAN DIEGO, CALIF.--BioVectra announced today a new
agreement naming BioVectra as a non-exclusive agent of Reagent Proteins
in North America and Europe. BioVectra will provide its customers
access to Reagent Proteins’ unique range of over 5,000 catalog protein
products; as well as actively promoting Reagent Proteins’ capabilities
through its agency network and directly to its key customers, including
the potential for custom projects.
“We are pleased to establish
this distribution relationship with BioVectra." stated Patrick K. Lucy,
Vice President, Business Development and Marketing at Pfenex Inc.,
“Leveraging BioVectra’s experienced business development and sales team,
as well as an extensive supply chain network, provides the North
American and European markets with additional access to our catalog of
proteins and services.”
“BioVectra is proud to add the Reagent
Proteins catalog to our portfolio of products and services including:
cGMP custom manufacturing and key cGMP reagents and both biologic and
synthetic API’s, from fermentation, synthesis, and natural product
extraction,” Heather Delage, Director of Worldwide Sales & Marketing
at BioVectra said, “This cGMP experience makes BioVectra a unique
agent, able to leverage its operations and quality assurance
understanding to meet the exact individual needs of biologic drug
manufacturers.”
About Reagent Proteins
Located in San Diego,
California, Reagent Proteins is a leading manufacturer and supplier of
reagent, pre-clinical and cGMP grade recombinant proteins to the
biopharmaceutical and vaccine development community. Reagent Proteins
is a division of Pfenex Inc. Headquartered in San Diego, California,
Pfenex is a biotechnology company leveraging the proprietary Pfenex
Expression Technology™ platform for the development of biosimilars and
innovative vaccines to address unmet and growing global healthcare
needs.
About BioVectra
Based in Prince Edward Island, Canada,
BioVectra Inc. is an innovative cGMP drug development partner, custom
manufacturer of API’s and bioprocess reagent supplier with over 40 years
of experience serving the pharmaceutical, diagnostic and biotechnology
industries. BioVectra is the world’s leading manufacturer of
dithiothreitol (DTT). The company holds 8 DMF and 2 VMF filings, and
has experience in technology-partnering and development of API’s for
both NCE and generic development pathways.
